Cedar Brook Financial Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,375	Closed	-$312K	–	349
2021 Q2	$312K	Sell	3,375 -448	-12%	-$41.4K	0.09%	261
2021 Q1	$339K	Buy	3,823 +1,074	+39%	+$95.2K	0.12%	204
2020 Q4	$256K	Buy	+2,749	New	+$256K	0.09%	246